Fermenta Biotech Ltd

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced its Q1FY27 earnings presentation, with revenue near flat sequentially at INR 126.2 crore, driven by a 24% QoQ increase in human nutrition revenue to INR 76.5 crore. The company's largest business segment, human nutrition, contributed 61% to the revenue, while animal nutrition remained a soft spot with volumes down 52% QoQ and 20% YoY. Fermenta's EBITDA declined 37% YoY to INR 9.5 crore, and profit after tax was down 56% YoY to INR 11.6 crore.

Fermenta Biotech Ltd

Fermenta Biotech Ltd announced unaudited financial results for Q1FY27, with consolidated revenue of INR 126.2 crore, down 13% YoY and flat QoQ. EBITDA was INR 22.4 crore, down 39% YoY and 11% QoQ. Profit after tax was INR 9.5 crore, down 56% YoY and 49% QoQ.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at a meeting held on August 11, 2026. The company has enclosed the Limited Review Reports on the financial results issued by M/s. SRBC & Co. LLP, Chartered Accountants, with an unmodified opinion.

Fermenta Biotech Ltd

Fermenta Biotech Ltd's board meeting on August 11, 2026, approved unaudited financial results for the quarter ended June 30, 2026. The company received an unmodified opinion from statutory auditors SRBC & Co. LLP.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on August 17, 2026, in Mumbai, where the company officials will discuss press releases and investor presentations available on the company's website and BSE's website.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has listed its shares on the National Stock Exchange (NSE) under the symbol FERMENTA and ISIN INE225B01021, expanding its capital-market presence and increasing accessibility to a wider community.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has been listed on the National Stock Exchange of India Limited (NSE) with effect from August 04, 2026. The company's existing 2,94,30,987 equity shares have been admitted to dealings on the NSE.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has announced an investor meeting on July 29, 2026, in Mumbai. The meeting will be held one-to-one with investors, and the company will discuss press releases and investor presentations available on its website. No unpublished price-sensitive information will be discussed during the interaction.

Fermenta Biotech Ltd

Fermenta Biotech Ltd has published a notice for its 74th Annual General Meeting (AGM) in newspapers as per SEBI regulations.

Fermenta Biotech Ltd

Fermenta Biotech Ltd announced an upcoming one-to-one physical meeting with investors in Mumbai on June 26, 2026. During the interaction, company officials will discuss the audited financial results for the year ended March 31, 2026, utilizing the previously uploaded press release and investor presentation. The company explicitly stated that no unpublished price sensitive information (UPSI) will be disclosed during this meeting.